Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018104540) RNAS FOR WOUND HEALING
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/104540 International Application No.: PCT/EP2017/082108
Publication Date: 14.06.2018 International Filing Date: 08.12.2017
IPC:
A61K 48/00 (2006.01) ,A61P 17/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
02
for treating wounds, ulcers, burns, scars, keloids, or the like
Applicants:
CUREVAC AG; Paul-Ehrlich-Str. 15 72076 Tübingen, DE
Inventors:
HORSCROFT, Nigel; DE
PÖNISCH, Marion; DE
WEINL, Christine; DE
Agent:
VON STOSCH, Andreas; DE
LEHMBACHER, Michael; DE
EICHELBAUM, Kornelia; DE
HAHNER, Nadja; DE
Priority Data:
PCT/EP2016/08026008.12.2016EP
Title (EN) RNAS FOR WOUND HEALING
(FR) ARN POUR LA CICATRISATION DES PLAIES
Abstract:
(EN) The present invention relates to an RNA encoding a therapeutic protein, in particular a collagenase, growth factor, cytokine, receptor, chaperone or signal transduction inhibitor. In particular, the present invention relates to RNA suitable for treatment of wounds, specifically for promoting wound healing. The present invention concerns such RNA as well as pharmaceutical compositions and kits and combinations comprising the RNA. Furthermore, the present invention relates to the RNA, pharmaceutical compositions, kits as disclosed herein for use in the treatment of wounds, specifically for promoting wound healing.
(FR) La présente invention concerne un ARN codant une protéine thérapeutique, en particulier une collagénase, un facteur de croissance, une cytokine, un récepteur, une chaperone ou un inhibiteur de transduction de signal. Plus particulièrement, la présente invention concerne un ARN approprié pour le traitement de plaies, en particulier destiné à favoriser la cicatrisation des plaies. La présente invention concerne un nouvel ARN ainsi que des compositions, des kits et des combinaisons comprenant ledit ARN. En outre, la présente invention concerne l'ARN, des compositions pharmaceutiques, des kits tels que décrits dans la description destinés à être utilisés dans le traitement de plaies, en particulier en vue de favoriser la cicatrisation des plaies.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)